Progression rates of diabetic neuropathy in placebo patients in an 18-month clinical trial. Ponalrestat Study Group.

Laudadio, C

Progression rates of diabetic neuropathy in placebo patients in an 18-month clinical trial. Ponalrestat Study Group. [electronic resource] - Journal of diabetes and its complications - 121-7 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.

1056-8727

10.1016/s1056-8727(97)00074-3 doi


Diabetic Neuropathies--drug therapy
Disease Progression
Double-Blind Method
Electrophysiology--methods
Humans
Hypoglycemic Agents--therapeutic use
Median Nerve--physiopathology
Neural Conduction
Neurons, Afferent--physiology
Phthalazines--therapeutic use
Placebos
Reflex
Single-Blind Method
Sural Nerve--physiopathology
Time Factors
Ulnar Nerve--physiopathology
Valsalva Maneuver